Total debt of $365.0M against $435.6M of equity yields a 0.67 debt-to-equity ratio, down from 3.80 two years earlier, though absolute debt has remained broadly flat near $340M to $390M, suggesting deleveraging has been driven by equity rebuilding rather than debt repayment.
Nutex Health, Inc. (NUTX) balance sheet — 13-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'11 | Dec'10 |
|---|
| Total Current Assets | 633.24M | 538.81M | 292.48M | 90.85M | 97.97M | 154.02M | 135.51M | 45.74M | 305.42K | 55.08K | 507.93K | 7.63M | 1.76M | 2.22M |
| Cash & Short-Term Investments | 249.91M | 185.57M | 43.58M | 22M | 34.26M | 36.12M | 25.51M | 8M | 119.27K | 9.45K | 10.52K | 122.29K | 224.8K | 465.55K |
| Cash Only | 249.91M | 185.57M | 43.58M | 22M | 34.26M | 36.12M | 25.51M | 8M | 119.27K | 9.45K | 10.52K | 122.29K | 224.8K | 465.55K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 360.84M | 325.42M | 236.05M | 62.78M | 58.32M | 114.76M | 108.14M | 36.14M | 186.15K | 6.25K | 15K | 0 | 720.87K | 613.65K |
| Days Sales Outstanding | 158.38 | 135.71 | 179.52 | 92.52 | 97.06 | 126.34 | 144.04 | 135.91 | 49.7 | 98.54 | - | - | 103.24 | 176.87 |
| Inventory | 5.14M | 2.87M | 2.85M | 3.39M | 3.53M | 2.81M | 1.73M | 899.91K | 27.07K | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 3.71 | 2.43 | 3.67 | 5.81 | 6.33 | 6.75 | 5.41 | 8.18 | 19.45 | - | - | - | - | - |
| Other Current Assets | 3.65M | 24.95M | 10M | 2.68M | 1.87M | 323.28K | 0 | 0 | -27.07K | 39.38K | 482.41K | 7.27M | 754.77K | 812.73K |
| Total Non-Current Assets | 399.13M | 379.71M | 362.84M | 307.4M | 333.78M | 240.63M | 173.05M | 133.48M | 144.01K | 3.27M | 2.9K | 3.38K | 313.77K | 116.11K |
| Property, Plant & Equipment | 361.21M | 343.9M | 324.69M | 269.39M | 295.15M | 238.36M | 170.81M | 131.28M | 7.61K | 3.85K | 1.18K | 1.66K | 18.56K | 5.09K |
| Fixed Asset Turnover | 2.30x | 2.55x | 1.48x | 0.92x | 0.74x | 1.39x | 1.60x | 0.74x | 179.58x | 6.02x | - | - | 137.30x | 248.94x |
| Goodwill | 13.92M | 13.92M | 13.92M | 17.07M | 17.01M | 1.14M | 1.14M | 3.47M | 0 | 0 | 0 | 0 | 111.03K | 111.03K |
| Intangible Assets | 20.25M | 21.23M | 15.53M | 20.51M | 21.19M | 682.65K | 0 | 1.54M | 2.57M | 3.27M | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 116.96K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.75M | 662K | 711.35K | 431.13K | 423.43K | 456.08K | 1.1M | -2.81M | 19.43K | 1.95K | 1.72K | 1.72K | 0 | 0 |
| Total Assets | 1.03B | 918.52M | 655.32M | 398.25M | 431.75M | 394.65M | 308.55M | 179.22M | 449.43K | 3.33M | 510.83K | 7.64M | 2.07M | 2.33M |
| Asset Turnover | 0.82x | 0.95x | 0.73x | 0.62x | 0.51x | 0.84x | 0.89x | 0.54x | 3.04x | 0.01x | - | - | 1.23x | 0.54x |
| Asset Growth % | 87.54% | 40.16% | 64.55% | -7.76% | 9.4% | 27.9% | 72.16% | 39778.36% | -86.5% | 551.63% | -93.31% | 268.48% | -11.2% | - |
| Total Current Liabilities | 132.94M | 157.91M | 140.87M | 58.31M | 54.86M | 37.69M | 31.45M | 72.13M | 1.04M | 959.78K | 6.38M | 6.08M | 288.58K | 351.62K |
| Accounts Payable | 10.18M | 48.97M | 13.96M | 25.28M | 23.93M | 17.65M | 8.63M | 1.75M | 567.01K | 348.35K | 356K | 168.97K | 263.19K | 326.23K |
| Days Payables Outstanding | 26.22 | 41.47 | 17.96 | 43.35 | 42.84 | 42.32 | 27.06 | 15.93 | 407.27 | 225.3 | 274.72K | 93.16K | 62.81 | 152.04 |
| Short-Term Debt | 8.17M | 14.08M | 17.95M | 14.18M | 15.17M | 10.23M | 18.65M | 13.35M | 477.06K | 386.19K | 50K | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 173.92K | 38.65K | 165.56K | 0 | 9.1K | 0 | 811.23K | 0 | 0 |
| Other Current Liabilities | 66.79M | 8.26M | 0 | 0 | 5.61M | 3.6M | -38.65K | 3.37M | 0 | 216.14K | 5.97M | 5.1M | 25.39K | 25.39K |
| Current Ratio | 4.76x | 3.41x | 2.08x | 1.56x | 1.79x | 4.09x | 4.31x | 0.63x | 0.29x | 0.06x | 0.08x | 1.26x | 6.10x | 6.31x |
| Quick Ratio | 4.72x | 3.39x | 2.06x | 1.50x | 1.72x | 4.01x | 4.25x | 0.62x | 0.27x | 0.06x | 0.08x | 1.26x | 6.10x | 6.31x |
| Cash Conversion Cycle | 135.87 | 96.66 | 165.22 | 54.99 | 60.55 | 90.77 | 122.39 | 128.16 | -338.12 | - | - | - | - | - |
| Total Non-Current Liabilities | 358.52M | 337.18M | 312.56M | 260.83M | 256.56M | 165.38M | 129.73M | 56.26M | 902.72K | 0 | 0 | 0 | 181.69K | 0 |
| Long-Term Debt | 34.2M | 29.17M | 22.47M | 26.31M | 23.05M | 78.82M | 81.9M | 40.88M | 902.72K | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1.21B | 298.91M | 290.1M | 229.37M | 223.06M | 86.56M | 47.83M | 15.38M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 38.91M | 9.09M | 0 | 5.15M | 10.45M | 1.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | -1.75M | 0 | 0 | 0 | 0 | 0 | 0 | 181.69K | 0 |
| Total Liabilities | 491.47M | 495.09M | 453.43M | 319.14M | 311.42M | 203.07M | 161.19M | 128.39M | 1.95M | 959.78K | 6.38M | 6.08M | 470.27K | 351.62K |
| Total Debt | 364.98M | 351.39M | 340.3M | 275.76M | 267.2M | 178.55M | 150.12M | 119.94M | 1.38M | 386.19K | 50K | 0 | 0 | 0 |
| Net Debt | 115.07M | 165.82M | 296.72M | 253.75M | 232.95M | 142.43M | 124.61M | 111.94M | 1.26M | 376.74K | 39.48K | -122.29K | -224.8K | -465.55K |
| Debt / Equity | 0.67x | 0.83x | 1.69x | 3.49x | 2.22x | 0.93x | 1.02x | 2.36x | - | 0.16x | - | - | - | - |
| Debt / EBITDA | 1.10x | 1.19x | 2.27x | - | - | 1.00x | 0.94x | 3.23x | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.35x | 0.56x | 1.98x | - | - | 0.80x | 0.78x | 3.01x | - | - | - | - | - | - |
| Interest Coverage | 16.22x | 12.01x | 6.51x | -1.97x | -32.60x | 28.35x | 23.66x | 10.09x | -7.65x | -15.35x | -173.90x | -169.42x | - | - |
| Total Equity | 540.91M | 423.44M | 201.89M | 79.11M | 120.33M | 191.58M | 147.37M | 50.84M | -1.5M | 2.37M | -5.87M | 1.56M | 1.6M | 1.99M |
| Equity Growth % | 244.63% | 109.73% | 155.22% | -34.26% | -37.19% | 30% | 189.89% | 3495.03% | -163.21% | 140.36% | -475.93% | -2.58% | -19.27% | - |
| Book Value per Share | 76.81 | 62.67 | 39.59 | 17.94 | 28.43 | 48.48 | 34.34 | 12.28 | -0.21 | 0.57 | -2.84 | 0.76 | 1.34 | 1.66 |
| Total Shareholders' Equity | 435.57M | 329.45M | 146.34M | 61.45M | 95.86M | 114.65M | 85.81M | 28.31M | -1.5M | 2.37M | -5.87M | 1.56M | 1.6M | 1.99M |
| Common Stock | 7K | 7K | 5.51K | 676.68K | 650.22K | 592.79K | 5.28K | 4.65K | 1.77K | 126.2K | 39.71K | 39.68K | 0 | 0 |
| Retained Earnings | -133.31M | -286.19M | -356.89M | -409.07M | -363.29M | 102.32M | -18.22M | -12.57M | -5.45M | -9.65M | -10.23M | -2.8M | -824.45K | -441.06K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1M | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 105.34M | 93.99M | 55.55M | 17.65M | 24.46M | 76.93M | 61.56M | 22.53M | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying NUTX stock.
As of 2025, Nutex Health, Inc. (NUTX) had total assets of $918.5M including $538.8M in current assets.
Nutex Health, Inc. (NUTX) carries total debt of $351.4M, offset by $185.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Nutex Health, Inc. (NUTX) has total shareholders' equity (book value) of $329.4M ($62.67 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Nutex Health, Inc. (NUTX) reported a current ratio of 3.41x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Liquidity Dependence on Working Capital Timing
Metrics are mathematically derived from official filings.
Balance Sheet Rebuilt From Equity Deficit
Based on Nutex's reported figures, total equity rose from $60.4M in 2024Q3 to $435.6M in 2026Q3 while accumulated deficit narrowed from -$418.6M to -$133.3M, indicating the balance sheet has strengthened substantially over the period.
The improvement appears driven primarily by retained earnings recovery and the cumulative effect of profitable quarters, rather than external equity infusions that the supplied data does not clearly document. The steady decline in the debt-to-equity ratio from 3.80 to 0.67 suggests the equity base is now carrying a much larger share of the asset structure, which investors should monitor for whether the trend holds through a weaker earnings period.
Leverage Moderated but Debt Remains Material
According to the reported balance sheet, total debt of $365.0M in 2026Q3 against $435.6M of equity yields a 0.67 debt-to-equity ratio, down from 3.80 two years earlier, though absolute debt has remained broadly flat near $340M to $390M.
The reduction in leverage ratio reflects equity growth more than debt repayment, since gross debt has been relatively stable across the ten reported quarters. This suggests the company has not meaningfully deleveraged in absolute terms, so refinancing and interest-coverage risk remain relevant if operating earnings soften. The debt load warrants monitoring alongside the wide gap between operating and net margins in the income statement.
Cash Buffer Strong but Quarterly Volatile
Based on Nutex's reported figures, cash of $249.9M in 2026Q3 against a current ratio of 4.76 indicates ample short-term coverage, though cash has moved between $40.8M and $249.9M across the ten quarters.
The current ratio and cash balance together suggest near-term obligations are well covered, but the sharp swings in cash point to dependence on collection timing rather than a steady liquidity base. Given the working-capital-driven cash swings noted in the cash flow analysis, the current cash position may be less representative of durable liquidity than the headline figure implies.
Asset Base Anchored by Fixed Facilities
As reported in the financial statements, net PP&E of $361.2M represents roughly 36% of total assets of $1.0B in 2026Q3, while goodwill is a minor $13.9M, indicating the asset base is predominantly tangible and facility-linked.
The composition points to a capital-intensive, asset-heavy operating model in which physical hospital infrastructure drives the balance sheet rather than acquired intangibles. The low goodwill balance reduces impairment risk materially, though the reliance on PP&E means returns depend on sustained facility utilization and on-going capital maintenance.
Deficit Recovery Masks Earnings Dispersion
Based on reported quarterly figures, the rebuilt equity may overstate underlying balance sheet durability, given that net margin has ranged widely and the 2026Q3 operating margin of 35.4% compares with a net margin of 18.5%.
The most material distortion is that equity recovery depends on earnings that have proven uneven, so a single weak quarter could reverse part of the accumulated deficit improvement. Investors should monitor whether the balance sheet strength reflects sustained earnings power or a favorable run of collections that may not persist.